Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Bucknelly21on Dec 20, 2022 12:25pm
120 Views
Post# 35182408

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RMD timing

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RMD timing

Agree unfortunately this is what happens when dubuc is calling the shots in the ir department, he unfortunately is unwilling to realize that his methods are awful and not effective. Every time  we have an event they do the exact opposite of what they should, most likely because the little shareholders mean nothing to this company which is why they are always updating the big shareholders and not the little ones during critical times

Wino115 wrote: I think we need to wait for the plan to hit breakeven, restart final enrollment, sales expectations, etc... and then you can have a much better sense. I showed you some numbers you could do if you absoltely had to cut to breakeven so you can move on as a much more profitable company in the future if you need to. They can ratchet down a lot of that spending. 

Trogarzon wrote:

Wino.. since you seem to be the most informed shareholder.     Could we organise a collective action to get more clarity on the future of the company.  Can we rely on the actual BOD and CEO/CFO to keep this company afloat in the near term.  Honestly I'm at the point where I think this is our last chance as shareholders to have our say in what's going to be the priorities going forward.  What are the odds at this point Marathon our celebrated credit savior becomes our worst nightmare in a few years.




 

<< Previous
Bullboard Posts
Next >>